|
US6960579B1
(en)
|
1998-05-19 |
2005-11-01 |
Alcon Manufacturing, Ltd. |
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
|
|
GB9902047D0
(en)
*
|
1999-01-29 |
1999-03-17 |
Cerebrus Ltd |
Chemical compounds XI
|
|
US6465467B1
(en)
|
1999-05-21 |
2002-10-15 |
Biovitrum Ab |
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
|
|
GB9918965D0
(en)
*
|
1999-08-11 |
1999-10-13 |
Cerebrus Ltd |
Chemical compounds xxi
|
|
WO2001040183A1
(en)
*
|
1999-12-03 |
2001-06-07 |
Alcon Universal Ltd. |
1-aminoalkyl-1h-indoles for treating glaucoma
|
|
US6806285B1
(en)
|
2000-03-17 |
2004-10-19 |
Alcon, Inc. |
5-Hydroxyl indole derivatives for treating glaucoma
|
|
BR0109193A
(pt)
*
|
2000-03-17 |
2003-05-27 |
Alcon Inc |
Compostos com atividade agonista 5-ht2 e 5-ht1a para tratamento do glaucoma
|
|
US7012090B1
(en)
|
2000-03-17 |
2006-03-14 |
Alcon, Inc. |
Pyranoindoles for treating glaucoma
|
|
GB0019950D0
(en)
*
|
2000-08-12 |
2000-09-27 |
Smithkline Beecham Plc |
Compounds
|
|
IL155875A0
(en)
|
2000-11-20 |
2003-12-23 |
Biovitrum Ab |
Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
|
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
|
HUP0303316A2
(hu)
|
2000-12-20 |
2004-01-28 |
Bristol-Myers Squibb Pharma Company |
Aril- és amino-aril-szubsztituált szerotoninreceptor agonista és antagonista ligandumok és ezeket tartalmazó gyógyszerkészítmények
|
|
JP2004532887A
(ja)
|
2001-06-01 |
2004-10-28 |
アルコン，インコーポレイテッド |
新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用
|
|
CA2447480A1
(en)
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Pyranoindazoles and their use for the treatment of glaucoma
|
|
JP2004534781A
(ja)
|
2001-06-01 |
2004-11-18 |
アルコン，インコーポレイテッド |
新規なアリールアミノプロパン類似体および緑内障治療へのこれらの使用
|
|
US6884816B2
(en)
|
2001-08-31 |
2005-04-26 |
Alcon, Inc. |
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
|
|
TW593302B
(en)
|
2001-12-20 |
2004-06-21 |
Alcon Inc |
Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
|
|
CN100484933C
(zh)
|
2002-06-19 |
2009-05-06 |
比奥维特罗姆股份公开公司 |
新的吡嗪化合物及其在制备用于治疗与5-羟色胺相关的疾病的药物中的用途
|
|
JP2006501245A
(ja)
*
|
2002-08-30 |
2006-01-12 |
アルコン，インコーポレイテッド |
置換された５−クロマン−５−イル−エチルアミン化合物および緑内障の治療のためのその使用
|
|
US7795280B2
(en)
|
2002-11-07 |
2010-09-14 |
N.V. Organon |
Indoles useful in the treatment of androgen-receptor related diseases
|
|
BR0316775A
(pt)
|
2002-12-13 |
2005-11-01 |
Alcon Inc |
Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
|
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
|
GB0314967D0
(en)
*
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
US7476687B2
(en)
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
|
TW200520760A
(en)
|
2003-12-15 |
2005-07-01 |
Alcon Inc |
Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
|
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
|
EP2248524A3
(en)
|
2004-08-25 |
2011-03-09 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for stress urinary incontinence and method of screening the same
|
|
US7425572B2
(en)
|
2004-12-08 |
2008-09-16 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
|
CN101151249B
(zh)
*
|
2005-03-31 |
2011-04-06 |
辉瑞产品公司 |
环戊吡啶及四氢喹啉衍生物
|
|
AP2007004144A0
(en)
*
|
2005-03-31 |
2007-08-31 |
Pfizer Prod Inc |
Cyclopentapyridine and tetrahydroquinoline derivatives
|
|
EP2742936A1
(en)
|
2006-05-16 |
2014-06-18 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
|
AU2007274710A1
(en)
*
|
2006-07-14 |
2008-01-24 |
Pfizer Products Inc. |
Tartrate salt of (7S)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2R)-2-methylpiperazin-1-yl]-6,7-dihydro-5H-cyclopenta[b]pyridine
|
|
GB0715047D0
(en)
*
|
2007-08-02 |
2007-09-12 |
Glaxo Group Ltd |
Novel Compounds
|
|
EP2789338A3
(en)
|
2007-11-15 |
2015-01-14 |
Takeda Pharmaceutical Company Limited |
Condensed pyridine derivate and use thereof
|
|
KR101062376B1
(ko)
|
2008-04-10 |
2011-09-06 |
한국화학연구원 |
신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
|
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
CN109071435A
(zh)
*
|
2016-01-21 |
2018-12-21 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
吲哚啉衍生物、包含它们的组合物及其用途
|
|
WO2018009854A1
(en)
*
|
2016-07-08 |
2018-01-11 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Indoline derivatives and method for using and producing the same
|
|
WO2018064465A1
(en)
|
2016-09-29 |
2018-04-05 |
The Regents Of The University Of California |
Compounds for increasing neural plasticity
|
|
EP3733204A4
(en)
|
2017-12-27 |
2021-09-15 |
Takeda Pharmaceutical Company Limited |
THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE
|
|
AU2020228289B2
(en)
*
|
2019-02-27 |
2026-02-05 |
The Regents Of The University Of California |
N-substituted indoles and other heterocycles for treating brain disorders
|
|
CN113784962B
(zh)
|
2019-02-27 |
2025-04-25 |
加利福尼亚大学董事会 |
用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
|
|
KR20230066543A
(ko)
*
|
2020-06-10 |
2023-05-16 |
델릭스 테라퓨틱스, 인크. |
이소트립타민 사이코플라스토겐 및 이의 용도
|
|
TW202333668A
(zh)
|
2021-12-15 |
2023-09-01 |
美商德利克斯醫療公司 |
經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
|
|
KR20250034020A
(ko)
*
|
2022-04-19 |
2025-03-10 |
마인드셋 파마 인크. |
세로토닌 관련 장애를 치료하는 데 유용한 세로토닌성 제제로서의 인돌린 유도체
|